Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.

Elena, Chiara; Gallì, Anna; Such, Esperanza; Meggendorfer, Manja; Germing, Ulrich; Rizzo, Ettore; Cervera, Jose; Molteni, Elisabetta; Fasan, Annette; Schuler, Esther; Ambaglio, Ilaria; Lopez-Pavia, Maria; Zibellini, Silvia; Kuendgen, Andrea; Travaglino, Erica; Sancho-Tello, Reyes; Catricalà, Silvia; Vicente, Ana I; Haferlach, Torsten; Haferlach, Claudia; Sanz, Guillermo F; Malcovati, Luca; Cazzola, Mario

Elena, Chiara; Gallì, Anna; Such, Esperanza; Meggendorfer, Manja; Germing, Ulrich; Rizzo, Ettore; Cervera, Jose; Molteni, Elisabetta; Fasan, Annette; Schuler, Esther; Ambaglio, Ilaria; Lopez-Pavia, Maria; Zibellini, Silvia; Kuendgen, Andrea; Travaglino, Erica; Sancho-Tello, Reyes; Catricalà, Silvia; Vicente, Ana I; Haferlach, Torsten; Haferlach, Claudia; Sanz, Guillermo F; Malcovati, Luca; Cazzola, Mario.

Afiliação

Elena C; Department of Molecular Medicine, University of Pavia, Pavia, Italy; Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;
Gallì A; Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;
Such E; Department of Hematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain;
Meggendorfer M; Munich Leukemia Laboratory GmbH, Munich, Germany;
Germing U; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany;
Rizzo E; Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy;
Cervera J; Department of Hematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain;
Molteni E; Department of Molecular Medicine, University of Pavia, Pavia, Italy;
Fasan A; Munich Leukemia Laboratory GmbH, Munich, Germany;
Schuler E; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany;
Ambaglio I; Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;
Lopez-Pavia M; Department of Hematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain;
Zibellini S; Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;
Kuendgen A; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany;
Travaglino E; Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;
Sancho-Tello R; Department of Hematology, Hospital Arnau de Vilanova, Valencia, Spain; and.
Catricalà S; Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;
Vicente AI; Department of Hematology, Hospital de La Ribera, Alzira, Spain.
Haferlach T; Munich Leukemia Laboratory GmbH, Munich, Germany;
Haferlach C; Munich Leukemia Laboratory GmbH, Munich, Germany;
Sanz GF; Department of Hematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain;
Malcovati L; Department of Molecular Medicine, University of Pavia, Pavia, Italy; Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;
Cazzola M; Department of Molecular Medicine, University of Pavia, Pavia, Italy; Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;

Blood ; 128(10): 1408-17, 2016 09 08.

Article em En | MEDLINE | ID: mdl-27385790

Assuntos

Biomarcadores Tumorais/genética; Aberrações Cromossômicas; Leucemia Mielomonocítica Crônica/genética; Mutação/genética; Medição de Risco/métodos; Adulto; Idoso; Idoso de 80 Anos ou mais; Tomada de Decisão Clínica; Estudos de Coortes; Feminino; Seguimentos; Humanos; Leucemia Mielomonocítica Crônica/patologia; Masculino; Pessoa de Meia-Idade; Gradação de Tumores; Fenótipo; Prognóstico; Fatores de Risco; Taxa de Sobrevida; Adulto Jovem

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielomonocítica Crônica / Biomarcadores Tumorais / Aberrações Cromossômicas / Medição de Risco / Mutação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google